Skip to main content
Top
Published in: Infection 2/1997

01-03-1997 | Originalia

IL-1β and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versusMycoplasma pneumoniae pneumonia

Authors: D. Lieberman, M. D., S. Livnat, M. D., F. Schlaeffer, M. D., A. Porath, M. D., M. P. H., S. Horowitz, Ph. D., Rachel Levy, Ph. D.

Published in: Infection | Issue 2/1997

Login to get access
Metadata
Title
IL-1β and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versusMycoplasma pneumoniae pneumonia
Authors
D. Lieberman, M. D.
S. Livnat, M. D.
F. Schlaeffer, M. D.
A. Porath, M. D., M. P. H.
S. Horowitz, Ph. D.
Rachel Levy, Ph. D.
Publication date
01-03-1997
Publisher
Springer-Verlag
Published in
Infection / Issue 2/1997
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/BF02113582

Other articles of this Issue 2/1997

Infection 2/1997 Go to the issue

BookReview

Book review

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine